119 related articles for article (PubMed ID: 16969488)
1. Comparison of CD44 expression in primary tumours and metastases of colorectal cancer.
Bendardaf R; Algars A; Elzagheid A; Korkeila E; Ristamäki R; Lamlum H; Collan Y; Syrjänen K; Pyrhönen S
Oncol Rep; 2006 Oct; 16(4):741-6. PubMed ID: 16969488
[TBL] [Abstract][Full Text] [Related]
2. CD44s expression mitigates the phenotype of human colorectal cancer hepatic metastases.
Pereira PA; Rubenthiran U; Kaneko M; Jothy S; Smith AJ
Anticancer Res; 2001; 21(4A):2713-7. PubMed ID: 11724345
[TBL] [Abstract][Full Text] [Related]
3. Expression of standard CD44 in human colorectal carcinoma: association with prognosis.
Huh JW; Kim HR; Kim YJ; Lee JH; Park YS; Cho SH; Joo JK
Pathol Int; 2009 Apr; 59(4):241-6. PubMed ID: 19351367
[TBL] [Abstract][Full Text] [Related]
4. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of CD44s expression in biliary tract cancers.
Lee SM; Lee KE; Chang HJ; Choi MY; Cho MS; Min SK; Lee HK; Mun YC; Nam EM; Seong CM; Lee SN
Ann Surg Oncol; 2008 Apr; 15(4):1155-60. PubMed ID: 18214619
[TBL] [Abstract][Full Text] [Related]
6. Role and prognostic significance of CD44s expression in colorectal cancer.
Visca P; Del Nonno F; Botti C; Marandino F; Sebastiani V; Di Tondo U; Donnorso RP; Trombetta G; Filippi S; Alo PL
Anticancer Res; 2002; 22(5):2671-5. PubMed ID: 12529980
[TBL] [Abstract][Full Text] [Related]
7. Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer.
Zlobec I; Günthert U; Tornillo L; Iezzi G; Baumhoer D; Terracciano L; Lugli A
Histopathology; 2009 Nov; 55(5):564-75. PubMed ID: 19912362
[TBL] [Abstract][Full Text] [Related]
8. MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastases.
Bendardaf R; Buhmeida A; Ristamäki R; Syrjänen K; Pyrhönen S
Scand J Gastroenterol; 2007 Dec; 42(12):1473-8. PubMed ID: 17852862
[TBL] [Abstract][Full Text] [Related]
9. Expression of the cell-cell adhesion molecule beta-catenin in colorectal carcinomas and their metastases.
Buhmeida A; Elzagheid A; Algars A; Collan Y; Syrjänen K; Pyrhönen S
APMIS; 2008 Jan; 116(1):1-9. PubMed ID: 18254773
[TBL] [Abstract][Full Text] [Related]
10. Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma.
Böhm JP; Niskanen LK; Pirinen RT; Kiraly K; Kellokoski JK; Moisio KI; Eskelinen MJ; Tulla HE; Hollmen S; Alhava EM; Kosma VM
J Pathol; 2000 Nov; 192(3):321-7. PubMed ID: 11054715
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of CD44 variant 6 expression and clinicopathological factors in pulmonary metastases from colon carcinoma.
Indinnimeo M; Cicchini C; Giarnieri E; Stazi A; Mingazzini PL; Stipa V
Oncol Rep; 2003; 10(6):1875-7. PubMed ID: 14534711
[TBL] [Abstract][Full Text] [Related]
12. Comparison of p53, Ki-67, and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer.
Sakai K; Kaku T; Kamura T; Kinukawa N; Amada S; Shigematsu T; Hirakawa T; Kobayashi H; Ariyoshi K; Nakano H
Gynecol Oncol; 1999 Mar; 72(3):360-6. PubMed ID: 10053108
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44v6 has no prognostic value in patients with colorectal cancer.
Jüngling B; Menges M; Goebel R; Wittig BM; Weg-Remers S; Pistorius G; Schilling M; Bauer M; König J; Zeitz M; Stallmach A
Z Gastroenterol; 2002 Apr; 40(4):229-33. PubMed ID: 11961731
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD44 in primary lung carcinomas using histological and cytological analyses.
Shimbori M; Kijima H; Sato S; Yoshida H; Sato T; Terasaki-Fukuzawa Y; Onoda N; Kanabuchi K; Abe Y; Nakamura M; Hattori M; Ohno E; Kuramoto H
Anticancer Res; 2003; 23(1A):115-21. PubMed ID: 12680202
[TBL] [Abstract][Full Text] [Related]
15. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of clinicopathological factors and the correlation between the adhesion molecule CD44 variant 9 expression and pulmonary metastases from colorectal cancers.
Goi T; Koneri K; Katayama K; Hirose K; Yamaguchi A
Int Surg; 2002; 87(2):130-6. PubMed ID: 12222916
[TBL] [Abstract][Full Text] [Related]
17. Decreased immunoexpression of standard form of CD44 is an independent favourable predictor of nodal metastasis in colorectal carcinoma.
Al-Maghrabi J; Gomaa W; Buhmeida A; Al-Qahtani M; Al-Ahwal M
Anticancer Res; 2012 Aug; 32(8):3455-61. PubMed ID: 22843930
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD44s and CD44v6 in transitional cell carcinomas of the urinary bladder: comparison with tumour grade, proliferative activity and p53 immunoreactivity of tumour cells.
Kuncová J; Urban M; Mandys V
APMIS; 2007 Nov; 115(11):1194-205. PubMed ID: 18092951
[TBL] [Abstract][Full Text] [Related]
19. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD44(v5-10) splicing variants in primary ovarian cancer and lymph node metastases.
Schröder W; Rudlowski C; Biesterfeld S; Knobloch C; Hauptmann S; Rath W
Anticancer Res; 1999; 19(5B):3901-6. PubMed ID: 10628329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]